.png){kind=icon}
Y
Yi‐Hsin Chan
H-index:34
Citation Count:4,372
Views:0
Biography
No content for now.
Education
No content for now.
Work Experience
No content for now.
Honors & Awards
No content for now.
Different Renal Function Estimation Formulas for Adverse Outcomes in Patients with Atrial Fibrillation Receiving Direct Oral Anticoagulants
心房颤动患者使用直接口服抗凝剂时不同肾功能估算公式与不良结局的关系
Heart Rhythm
IF5.7
Estimated Glomerular Filtration Rate Variability in Patients with Diabetes Receiving SGLT2 Inhibitors Versus DPP4 Inhibitors
估算肾小球滤过率变异性在糖尿病接受SGLT2抑制剂治疗的患者与接受DPP4抑制剂治疗的患者中的比较
Pioglitazone mitigates high-fat diet-induced cardiac lipotoxicity and vulnerable arrhythmias by reducing excess lipid intermediates
吡格列酮通过减少过量脂质中间产物，缓解高脂饮食诱导的心脏脂毒性及易损性心律失常。
Sex Differences in Clinical Outcomes and Surgical Interventions for Infective Endocarditis: A Nationwide Registry
感染性心内膜炎的临床结局和外科干预措施的性别差异：一项全国注册研究
Glycohemoglobin Variations and Long-term Risk of Incident Heart Failure in Patients With Type 2 Diabetes
糖化血红蛋白变异与2型糖尿病患者新发心力衰竭的长期风险
Stroke risks in women vs men in Asian patients with atrial fibrillation: A temporal trend analysis and a comparison of the CHA2DS2-VASc and CHA2DS2-VA stroke risk stratification scores
亚洲心房颤动患者中女性与男性的卒中风险：一项时间趋势分析及CHA2DS2-VASc和CHA2DS2-VA卒中风险分层评分的比较
Heart Rhythm
IF5.7
Adverse kidney events with initiation of SGLT2 inhibitors versus DPP4 inhibitors in diabetic people with a history of acute kidney injury
在具有急性肾损伤病史的糖尿病患者中，SGLT2抑制剂启动与DPP4抑制剂相比的不良肾脏事件
Effect of Initial eGFR and Albuminuria Changes on Clinical Outcomes in People With Diabetes Receiving SGLT2 Inhibitors
初始eGFR和尿白蛋白变化对接受SGLT2抑制剂治疗的糖尿病患者临床结局的影响
Risk of incident genitourinary cancer following hematuria in patients with atrial fibrillation receiving oral anticoagulants
房颤接受口服抗凝剂治疗的患者发生血尿后发生泌尿生殖系统癌症的风险
Heart Rhythm
IF5.7
